LexaGene Completes Prototype Assembly for Soon-To-Be First Fully Automated, Open-Access Pathogen Detection System
Dez 1st, 2017 | By brinvest | Category: Pinnacle ProfessorsNew Technology Will Revolutionize Pathogen Detection Across Food Safety, Veterinary and Human Clinical Diagnostics LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, has completed the assembly of its prototype for what will be the world’s first fully automated, open-access and on-site pathogen detection platform. The technology will be capable of screening for up to 22 pathogens at once and deliver results in just one hour – as opposed to three to five ... [more]